SPA
GBIO

Sherbrooke Park Advisers’s Generation Bio GBIO Stock Holding History

Sherbrooke Park Advisers’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,116
Closed -$31.5K – 1023
2024
Q2 		$31.5K Buy
+1,116
New +$36.3K 0.01% 864

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sherbrooke Park Advisers's GBIO Position: Q3 2024 in Review

Sherbrooke Park Advisers sold out of Generation Bio (GBIO) in Q3 2024, closing a stake of 1,116 shares — an estimated $31.5K sold.

Sherbrooke Park Advisers first reported a position in GBIO in Q2 2024 and held it in 1 quarter. The position peaked at $31.5K in Q2 2024. 75 funds tracked by Wall St. Rank hold GBIO as of Q3 2024.

  • Sherbrooke Park Advisers reported no remaining Generation Bio position as of Q3 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,116 Generation Bio shares in Q3 2024, an estimated $31.5K.
  • Sherbrooke Park Advisers first reported a position in Generation Bio in Q2 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Generation Bio position peaked at $31.5K in Q2 2024.
  • 75 funds tracked by Wall St. Rank held Generation Bio as of Q3 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.